Ann is the Senior Director and COO of the Engine. Ann was most recently at Sanofi where she held senior roles in business development and strategic venture investment. Ann joined Sanofi-Genzyme BioVentures in 2013 with a background in biotech partnering and early stage investment. Prior to SGBV, Ann was Senior Director, Corporate Development at Permeon Biologics and led a collaboration with a large pharmaceutical partner.Previously, Ann was also a Senior Associate at Flagship Ventures, an early stage venture capital firm investing in healthcare companies with over $900 million under management and was a Board observer for several portfolio companies. Ann started her career in R&D at 3M Company, working across fields of materials, biology, and engineering. Post-doctorate, she worked at 3M Company in corporate research and in business units, including 3M Pharmaceuticals, and was a Technical Circle of Excellence Award winner.While at Harvard, she was an entrepreneur-in-residence at Highland Capital Management and a founding team member of Novophage Therapeutics (now Sample6). Ann is also on the Life Sciences Council of Springboard Enterprises, an organization dedicated to building high-growth technology-oriented companies led by women. Ann holds a B.S. from the University of Illinois Urbana-Champaign, a Ph.D. from MIT in systems biology, and an M.B.A. from Harvard Business School.